Newsletter | November 20, 2026

11.20.26 -- Faster Clonal Cell Line Selection, Oncology Trials And CAR-T Delivery

VIDEO

Streamlining Clonal Cell Line Selection With Susan Sharfstein, Ph.D.

In this episode of “Better Biopharma,” host Tyler Menichiello is joined by Susan Sharfstein, Ph.D., a professor of nanoscale science and engineering at the University at Albany’s College of Nanotechnology, Science, and Engineering.

INDUSTRY INSIGHTS

How To Accelerate Early-Phase Oncology Trial

Purpose-built early-phase oncology sites can enroll patients within 7–10 days post-activation while maintaining quality and diversity; academic centers often lag due to complexity and saturation.

Why Community-Rooted Recruitment Is The Future Of Clinical Trials

Despite clinical trial awareness campaigns and site expansions, trials continue to fall short in reaching the patients who need them most, resulting in a shift toward community-rooted recruitment.

Process Intensification And Other Ways To Adapt To Changing Needs

As biologics manufacturing evolves, gain insight into why productivity depends on smarter investments, flexible production strategies, and supplier support that can address shifting modalities.

Lyophilization: Protecting And Preserving Biologics

Discover how lyophilization revolutionizes biologic drug manufacturing and ensures potent, stable treatments for complex diseases.

Accelerating Biologics With Seamless Technology Transfer

Uncover effective technology transfer strategies that can streamline scale-up, maintain product quality, and enable successful clinical and commercial manufacturing.

Eliminating Barriers To In Vivo And Ex Vivo CAR-T Delivery

Learn how lentiviral vector processes evolve for in vivo and ex vivo CAR‑T—covering yield, purity, scalability, and shifting regulatory demands for safe, consistent systemic delivery.

Connect With Life Science Leader: